News

Professor Aviv Nevo Returns to Cornerstone Research Expertise

Professor Aviv Nevo Returns to Cornerstone Research Expertise

Professor Aviv Nevo Rejoins Cornerstone Research

Professor Aviv Nevo, a highly regarded economist and expert in competition policy, has returned to Cornerstone Research after completing a pivotal two-year term as Director of the Bureau of Economics at the Federal Trade Commission (FTC). His experience and knowledge in economic analysis will significantly benefit Cornerstone's suite of consulting services.

Background and Experience of Professor Nevo

Aviv Nevo is celebrated for his extensive expertise in antitrust economics. During his tenure at the FTC, he played a crucial role in shaping modern market analysis through the development of the 2023 Merger Guidelines. These guidelines have greatly influenced merger reviews conducted by antitrust agencies, allowing for a nuanced understanding of competitive market dynamics.

Before his position at the FTC, Professor Nevo served as the Deputy Assistant Attorney General for Economic Analysis at the Antitrust Division of the Department of Justice (DOJ). His dual experience in both regulatory and academic environments equips him with a comprehensive perspective on antitrust laws and their applications.

Impact of Nevo's Return on Cornerstone Research

Rahul Guha, CEO of Cornerstone Research, expressed enthusiasm about Professor Nevo's return, stating, "Aviv's knowledge of industrial organization and econometrics provides essential insights for our clients navigating merger transactions and antitrust litigations." This sentiment is echoed by Kostis Hatzitaskos, Cohead of the antitrust and competition practice at Cornerstone Research, who points out that Professor Nevo's authoritative understanding of economic principles offers clients innovative approaches to complex challenges.

Expert Testimony and Major Cases

Professor Nevo's credentials are further highlighted by his participation as an expert in major federal cases. He was integral to the U.S. government's economic strategy in high-profile mergers, including the notable $37 billion merger between Aetna and Humana. His insights contributed to assessing the competitive implications of this substantial transaction.

In addition to Aetna and Humana, he has played a significant role in advising on the $400 million acquisition of Drew Marine Group and the $360 million acquisition of Farelogix by Sabre Corporation. His track record establishes him as a trusted authority on the economic ramifications of major business consolidations.

Leading the Conversation in Antitrust Policy

Professor Nevo's expertise extends to various notable antitrust litigations, where he has provided valuable independent analysis. His testimony in FTC v. Qualcomm involved addressing allegations concerning anti-competitive behavior and was recognized by Global Competition Review as a pivotal case in recent antitrust history.

Additionally, he has supported Qualcomm in multiple cases, including Apple v. Qualcomm and Qualcomm v. Korea Fair Trade Commission, showcasing his capability to articulate essential economic principles effectively across various jurisdictions.

Academic Roles and Achievements

Outside of his consulting work, Professor Nevo serves as a Penn Integrates Knowledge Professor at the University of Pennsylvania, where he teaches in both the economics department and the Wharton School's Business Economics and Policy and Marketing Departments. His leadership in the Wharton Competition and Policy Initiative positions him at the forefront of research in competition economics.

In recognition of his contributions to the field, he has been named to Global Competition Review's list of leading antitrust academics and received accolades from the American Antitrust Institute for his exceptional achievements in economic analysis for antitrust litigation.

About Cornerstone Research

Cornerstone Research is a prestigious consulting firm acclaimed for its expertise in economic and financial analysis. The firm collaborates with a network of eminent academics and industry experts to deliver insightful and rigorous consulting services to clients involved in complex disputes and regulatory investigations. Since its founding in 1989, Cornerstone has built a strong reputation for high-quality analysis, employing over 1,000 professionals across its nine global offices, including those in the U.S., the UK, and the EU.

Frequently Asked Questions

What role did Aviv Nevo hold at the FTC?

Aviv Nevo served as Director of the Bureau of Economics at the Federal Trade Commission.

What expertise does Professor Nevo bring to Cornerstone Research?

He brings extensive knowledge in antitrust economics, industrial organization, and econometrics.

What major cases has Professor Nevo testified in?

He has testified in several significant cases, including the merger between Aetna and Humana, and instances involving Qualcomm.

What is Cornerstone Research known for?

Cornerstone Research is known for providing economic and financial consulting and expert testimony in complex regulatory disputes and investigations.

What accolades has Aviv Nevo received for his work?

He has received recognition from Global Competition Review and the American Antitrust Institute for his contributions to economics in antitrust litigation.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 32

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 127

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 41

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 253

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 113

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 277

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 20

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 80

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 237

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading

Top 5 Most Recently Viewed Articles

Academy Sports + Outdoors Teams Up to Empower Military Families

Updated Category News Views 142

Academy Sports + Outdoors Supports Military Families This School Year In an inspiring initiative aimed at supporting military families, Academy Sports + Outdoors has partnered with Operation Homefront to provide essential school supplies for students heading back to class. As the back-to-school season approaches, these organizations are ensuring that military children...

Continue Reading
Repligen Corp's Q4 Earnings Reflect Strong Market Momentum

Updated Category News Views 232

Repligen Corp Highlights Strong Q4 Performance Repligen Corp (NASDAQ: RGEN) has recently reported its fourth-quarter earnings, showcasing an adjusted EPS of 44 cents. This is a slight decrease compared to the previous year's 48 cents but notably beats analysts’ consensus estimates of 41 cents. Sales Performance and Market Outlook The company reported sales hitting...

Continue Reading
Propanc Biopharma's Fiscal Year Highlights and Future Plans

Updated Category News Views 130

Propanc Biopharma's Recent Developments and Strategic Vision Propanc Biopharma, Inc. (NASDAQ: PPCB), a biopharmaceutical firm centered on innovations in cancer treatment, recently shared its year-end updates and strategic plans. As the financial year concluded on June 30, 2025, notable gains in the Company’s financial health have paved the way for exciting advancements....

Continue Reading
MIAX Strengthens Leadership with Key Executive Appointments

Updated Category News Views 253

MIAX Expands Leadership Team to Drive Market Growth Miami International Holdings, Inc. (NYSE: MIAX) is excited to unveil the new appointments of Shelly Brown and Joseph W. Ferraro III as part of its commitment to strategic growth in the futures market. These moves are aimed at enhancing leadership within MIAX Futures™, a core component of its expanding offerings in...

Continue Reading
Fortis Inc. Declares Upcoming Dividends for Shareholders

Updated Category News Views 137

Fortis Inc. Announces Upcoming Shareholder Dividends Fortis Inc. has officially declared dividends that are set to benefit its shareholders on March 1, 2025. This announcement is a key development for shareholders holding various classes of shares with specific dividends attached. The established record date for these dividends is February 18, 2025, marking an important...

Continue Reading